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Background: Since the advent of computed tomography and magnetic resonance imaging 
scans, neurological disorders have less often been falsely labeled as conversion disorder (CD). 
However, misdiagnosis of a neurological disorder as CD still occurs, especially in cases with 
insidious onset. Misinterpretation of la belle indifférence may contribute to such misdiagnosis. 
Here, we describe a case of progressive supranuclear palsy/Richardson’s syndrome (PSPS) 
misdiagnosed as a case of CD.
Case: A 62-year-old woman consulted two different neurologists in 2012 because of falling 
spells since 2009 and was diagnosed with CD. She was referred to the Clinical Center of Excel-
lence for Body, Mind, and Health for treatment of CD. After neurological examination, blood 
tests, and psychiatric examination, in which la belle indifférence and a history of incest were 
found, CD was confirmed. However, despite treatment for CD, the patient’s physical symptoms 
deteriorated over a year. After repeated physical and psychiatric examinations, neurocognitive 
assessment, and consultation with a third neurologist because of suspicion of neurological 
disease, the patient was diagnosed with PSPS.
Conclusion: La belle indifférence may be a psychological sign in the context of CD, but it may 
also be an expression of lack of mimic due to Parkinsonism or of eye movement disorder in 
the context of neurological illness. A diagnosis of CD should not be considered definitive if no 
improvement occurs in terms of physical, mental, and cognitive symptoms despite appropriate 
therapy. In case of deterioration, neurological reexamination and reinterpretation of la belle 
indifférence should be considered.
Keywords: conversion disorder, consultation, misdiagnosis, progressive supranuclear palsy, 
la belle indifférence, neurology
Introduction
Conversion disorder (CD), as stated in the Diagnostic and Statistical Manual of Mental 
Disorders, 5th edition (DSM-5),1 includes one or more deficits affecting either motor 
or sensory function that are incompatible with clinically recognized neurological or 
medical conditions, cannot be explained by any other medical or mental disorder, and 
cause clinically significant distress or impairment in occupational, social, or other 
important areas of functioning. The symptoms or deficits can be a sense of weakness 
or paralysis, abnormal movement (eg, tremor or myoclonus), swallowing or speech 
symptoms, seizure-like attacks, memory loss or anesthesia, special sensory symptoms, 
or mixed symptoms. CD can occur with or without a psychological stressor and is 
considered persistent if symptoms present themselves for over 6 months.1 The inci-
dence and prevalence of CD in the community are unclear.2 The incidence of CD in 
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3,781 patients referred to the neurologists in Scotland was 
6%.3 Misdiagnosis of an actual neurological disorder as CD 
was a frequent event until the 1970s.
In 1950, 29% of patients diagnosed with CD were found 
to have a previously missed neurological disease at follow-up. 
This number of misdiagnosed patients decreased to 17% in 
1960 and to 4% in 1970 – a drop explained by the introduc-
tion of computed tomography (CT) and magnetic resonance 
imaging (MRI) scans – and remained stable at that level.4,5 
Nevertheless, misdiagnosis of CD can still occur, especially 
in the early stages of a neurological disorder. This has become 
more relevant with the introduction of DSM-5 for CD, in 
which a life event or trauma in relation to the onset of CD is 
no longer required for classification. Since then, a tendency 
has been found to consider CD as a neurological disorder that 
can be established by a lack of clinical neurological findings 
and on the basis of a single neurological examination only.6 
However, slowly progressive neurological disorders may 
need longer follow-up, consultation with a psychiatrist, or a 
multidisciplinary approach.7
Here, we describe a case of progressive supranuclear 
palsy/Richardson’s syndrome (PSPS) misdiagnosed as CD. 
The patient presented to the Clinical Center of Excellence for 
Body, Mind, and Health as having CD, confirmed as such by 
two separate neurologists. However, she turned out to have 
PSPS after a year of treatment that led to improvement of 
her mental well-being but could not prevent physical and 
cognitive deterioration.
Case
A 62-year-old woman was referred to our outpatient clinic 
in February 2013, after visiting two different neurologists in 
2012 who diagnosed her with CD, followed by an unsuccess-
ful treatment episode in a rehabilitation clinic. The patient 
reported the following progressive problems since 2009: loss 
of power in the left arm and leg, and problems keeping her 
balance, sometimes resulting in a drunken gait and falling. In 
the 4 years before referral to our clinic, the patient had fallen 
spontaneously five times, without losing consciousness and 
with the ability to stand up immediately afterward. Further-
more, double vision occurred during fatigue, and the patient 
had difficulty articulating, difficulty finding words, pain in 
almost all joints and muscles, poor memory function, and 
difficulty in concentration due to which she could no longer 
read or solve puzzles – her favorite pastime. As a result, the 
patient experienced sleeping problems, low mood, no desire 
to perform activities, and a passive death wish.
In 2014, the patient again visited the neurological 
outpatient department. Anamnesis revealed progressive 
difficulties with speech and swallowing as well as falls due 
to balance disorder since 2009. On neurological examina-
tion, we saw a patient with a surprised look. Dysarthria was 
present, as well as a vertical upward supranuclear gaze palsy 
and slowing of downward vertical saccades. There was a 
prominent postural instability and a positive pull test. Snout 
reflexes were present. A left-sided striatal toe was seen. 
Rigidity and bradykinesia were present in legs more than 
arms. The applause sign was positive. Neither apraxia nor 
cortical sensory deficit was found, nor was there dysmetria 
or evidence of autonomic failure. Together with evidence of 
mesencephalon atrophy on MRI of the cerebrum and results 
on cognitive testing (described further), we concluded that 
the patient fulfilled the National Institute for Neurological 
Disorders and Stroke and Society for PSP criteria (NINDS-
SPSP) criteria for probable PSPS.
Biography and treatment history
For the past 10 years, the patient had suffered from mild 
depressive symptoms, for which she had received outpatient 
psychiatric treatment. In her childhood, between 12 and 
18 years, the patient and her siblings had been victims of 
incest by an uncle, which her mother would not believe 
when she told her. The patient had received treatment for 
that issue and found good results, but she was still angry 
with her mother, and therefore, did not have contact with her 
anymore. She had been married for 10 years and had three 
children; one of her daughters developed borderline personal-
ity disorder (BPS). After 10 years, she went through a divorce 
because she found her husband insufficiently involved in 
the relationship. She later had another relationship, but her 
friend committed suicide, which came unexpectedly to her 
and was quite a shock. Since then, she lived alone and worked 
over her lifetime as a nurse in a general hospital. Now, she 
had retired. She still had contact with two of her children 
but was no longer in touch with her daughter who had BPS. 
Due to her physical symptoms, she received help at home 
and had fewer opportunities to pursue her hobbies. She was 
less outgoing for fear of falling. When she was younger, she 
used to consume alcohol, but she no longer did so.
The patient had been diagnosed with osteoarthritis, 
 fibromyalgia, and recurrent bursitis of both hips for 10 years. 
She used irbesartan/hydrochlorothiazide 300/12.5 mg once 
daily for hypertension, which was well regulated.
For her current problems, the patient visited two neu-
rologists in 2012, but they did not find any abnormalities 
on neurological examination, with the exception of inse-
cure gait and transient coordination disturbances, which 
did not present as ataxia. In the first hospital, a CT scan of 
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the brain and carotid duplex was done which revealed no 
pathology. In the second hospital, which she visited in 2012 
for a second opinion, an MRI scan of the cerebrum showed 
small arachnoidal cysts in the left fossa medialis and MRI 
of the cervical spine showed slight degeneration with right 
paramedian HNP C6–C7 and median HNP C5–C6 without 
myelopathy. These findings could not explain the patient’s 
symptoms; therefore, the most likely diagnosis appeared to 
be CD. This was discussed with the patient, and after treat-
ment in a rehabilitation clinic did not produce results, she 
was referred to our center for treatment of CD.
Family history
The patient’s mother and her daughter suffered from BPS. The 
patient and her siblings had suffered from incest by an uncle.
Assessment at the Clinical Center of 
Excellence for Body, Mind, and Health
Physical examination
In our center, two neurological examinations took place with 
a 2-month interval. In the first examination, the power of the 
left limbs was reduced, but this was no longer the case at the 
second examination. Her blood pressure was 160/85 mmHg. 
Screening blood tests were normal, and there were no indica-
tions of recent alcohol use. Levels of vitamins B1, B6, and B12 
were elevated, for which the patient took supplements.
Questionnaires/interview
At intake and during treatment, an assessment was carried 
out using the Outcome Questionnaire (OQ),8 Patient Health 
Questionnaire (PHQ-9),9 Generalized Anxiety Disorder Scale 
(GAD-7),10 Physical Symptom Scale (LKV-51),11 Short Form 
36 Health Survey (SF-36),12 and Brief Pain Inventory (BPI).13 
The scores are shown in Table 1.
Before the start of treatment, the scores on the OQ, 
PHQ-9, GAD-7, LKV-51, and BPI were 107, 20, 10, 27, and 3, 
respectively, and indicated above-average physical symptoms, 
significant pain, and inability to function in social roles, as 
well as major depressive disorder with concomitant anxiety 
disorder, or an anxious depression. The Mini International 
Neuropsychiatric Interview classification indicated a depres-
sive episode. The Structured Clinical Interview for DSM 
Disorders-II (SCID II) interview showed avoidant personality 
characteristics.
Psychiatric examination
Psychiatric examination showed a friendly, elderly woman 
with a slightly unstable gait who made contact easily. Her 
facial expression was almost absent (Figure 1), and she 
discussed her symptoms with a somewhat surprised facial 
expression. The patient told us that she has always been like 
this, and it was part of her personality. Nevertheless, the 
surprised facial expression could be interpreted as la belle 
indifférence, but we could not be sure of it. Her speech was 
slightly monotonous without dysarthria.
Consciousness, attention, and concentration were normal 
during the examination despite her subjective complaints 
about concentration. No depersonalization or derealization 
was present. The patient did seem to dissociate several times 
for a short moment, that is, it seemed as if thinking became 
slow or stopped briefly a few times and was then resumed. 
Thinking and speech were slightly slow. Despite this, 
intelligence seemed normal. No psychotic symptoms were 
present. Mood seemed low, with a profound lack of affect. 
The patient was not suicidal.
Differential diagnosis
With these findings at assessment, the team discussed the 
following differential diagnostic considerations. There was a 
clear possibility of a neurological disorder, such as first signs 
of Parkinson’s disease or epilepsy, which might contradict 
the diagnosis of CD; however, such a neurological disorder 
had not been confirmed on neurological examinations, which 
included CT and MRI scans, so far.
Table 1 Routine outcome monitoring during treatment
Test Determinants measured by test T0 T1 T2 T3 T4 T5 T6 T7 T end
OQ Symptomatology, interpersonal 
relationships, social role8
107  135 114 99 108 110 125 94
PHQ-9 Depression9 20 24 23 23 26 21 22 21 22
GAD-7 Anxiety10 10 6  19 18 12 15 16 17
LKV-51 Physical symptoms11 27  41 42 20 13   14
SF-36 General health functioning12     19 21 21 23 23
BPI Severity of pain13 3   5 5 2   3
Notes: ´²µ LQGLFDWHV PLVVLQJ YDOXH DQGRU WKDW WKH VSHFLÀF TXHVWLRQQDLUH ZDV QRW ÀOOHG LQ DW WKH VSHFLÀF WLPH SRLQW 7 ZDV QRWHG DW LQLWLDO H[DPLQDWLRQ )ROORZXS
T assessments were conducted every 6 weeks.
Abbreviations: OQ, Outcome Questionnaire (cutoff 55); PHQ-9, Patient Health Questionnaire (cutoff 10); GAD-7, Generalized Anxiety Disorder (cutoff 10); 
LKV-51, Physical Symptom Checklist (Dutch abbreviation; cutoff 5); SF-36, Short Form 36 Health Survey (cutoff 12); BPI, Brief Pain Inventory (cutoff 3).
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
4.
32
.2
25
.7
7 
on
 1
9-
Ju
l-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
Neuropsychiatric Disease and Treatment 2017:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2060
van Meerkerk-Aanen et al
The fact that the patient had suffered from an incest 
experience in her childhood might fit with a diagnosis of 
CD, because a relationship between CD and childhood abuse 
has been found in previous studies,5,14 although, in DSM-5, 
incest is no longer considered necessary for or typical of 
CD.1,6 However, this experience had been well addressed 
in earlier treatment, and since then, the patient had lived 
for many decades without any signs of CD. Although she 
had anger issues toward her mother in relation to her incest 
experience, this was not a new development, and she had 
not suffered from significant related symptoms since then, 
unless the fibromyalgia, from which she had suffered for the 
last 10 years, is seen as a somatoform symptom. Although 
the patient did suffer from incest experiences in her youth, a 
divorce, and the loss of a friend by suicide in the past, there 
were no life events that could have been linked to the onset 
of her current physical symptoms.
The patient did suffer from avoidant personality charac-
teristics, which are often seen in CD. The patient did suffer 
from depression that, per the questionnaires, was much worse 
than would seem at first glance on psychiatric examination. 
However, this would actually argue against a diagnosis of 
CD, because in CD, emotional symptoms are normally lack-
ing in favor of neurological symptoms.
After careful consideration, despite some doubts because 
the neurological examinations did not yield an explanation 
and no clear actual psychological stressor could be identified, 
the patient received a working diagnosis of CD. She was 
also diagnosed with major depression, a pain disorder, and 
a personality disorder not otherwise specified, with avoidant 
characteristics.
This was discussed with the patient, who accepted this 
diagnosis and was willing to start treatment, hoping that 
in this way, her symptoms would subside. Furthermore, 
because of the positive outcome of earlier treatment for her 
incest experience, she trusted that she would benefit from 
psychiatric treatment again.
Treatment
Acceptance and commitment therapy was started and 
aimed at the acceptance of her physical symptoms through 
enhancing psychological flexibility and exploring life values. 
Daytime activities and support with practical matters were 
discussed in treatment sessions. The patient received therapy 
for her anger issues with her mother in relation to the early 
incest experience. For her pain, treatment with pregabalin 
was started but discontinued because of adverse effects at 
low doses. A psychosomatic physical therapist guided her 
through improving her coordination.
During treatment in our outpatient clinic, which lasted 
for more than a year and with which she was compliant, the 
patient’s anger toward her mother subsided, and she expe-
rienced better mental well-being. However, questionnaire 
monitoring as shown in Table 1 showed that depression, 
anxiety, physical symptoms, pain scores, and general health 
functioning (the SF-36)12 remained high. Moreover, a neu-
ropsychological assessment (NPA) was performed because 
of lack of improvement after a year. The results of this NPA 
are shown in Table 2.
Neuropsychological assessment
There were no indications of malingering. Attention and 
memory were intact. However, there were indications of 
impairment in visuoconstruction and working memory, and 
there were clear deficits in information-processing speed 
and executive functioning, particularly within the domain 
of verbal fluency, that is, letter fluency. The patient showed 
clear mental slowness and difficulty discerning and commu-
nicating emotions, which was interpreted as sign of la belle 
indifférence. The slowness was interpreted as fitting with a 
depressive disorder, which explains the impaired information-
processing speed, resulting in impaired verbal fluency. 
However, the profile might also fit neurological disorders.
This raised new suspicions because she also fell more 
often and had problems with swallowing and increased 
slowness of speech. Her physical symptoms deteriorated to 
such a degree that she could no longer visit our clinic or the 
Figure 1 A photograph of the surprised facial expression of the patient.
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physical therapist. Her symptoms were reassessed during a 
house call by the psychiatrist and psychologist.
After discussion within the team and with the patient’s 
general practitioner (GP), this course of events renewed 
suspicion of a neurological degenerative disorder despite 
the previous negative neurological findings, and a third 
neurologist was consulted by our center with the specific 
question to reconsider possible neurological disease as an 
explanation for the patient’s physical symptoms.
Neurological examination
During the neurological examination, the patient’s astonished 
look was noticed by the neurologist. Gaze was limited in the 
vertical plane, and vertical saccades were slowed (Figure 2). 
Pseudobulbar reflexes (snout) were present. Preservation of 
the oculocephalic reflex was also present (doll’s eye phe-
nomenon) at neurological examination (Figure 3). Bilateral 
bradykinesia as well as rigidity with axial predominance 
was present. There was severe postural instability. A left-
sided striatal toe was seen. The applause sign was positive. 
The patient fulfilled the NINDS-SPSP clinical criteria for 
probable PSPS.16 MRI scans (from 2012 and 2014) showed 
marked atrophy of the mesencephalon, resulting in the 
so-called hummingbird sign (Figure 4), a finding that is 
considered characteristic of PSPS.17
Evaluation of the patient
After this diagnosis by the third neurologist, we discussed 
the findings with the patient. Although no cure was avail-
able for her illness, the patient considered therapy and close 
monitoring within our center useful as she had worked 
through some issues in the relationship with her mother 
and because, with the help of monitoring and neurological 
consultation that had been established by our center, a diag-
nosis that explained her symptoms had finally been made, 
and she was thankful for this. Treatment at our center was 
no longer needed, and the patient moved to a nursing home 
for extensive care.
Table 2 Neuropsychological assessment
Test Test score
Visuoconstruction ROCFT  Copy65 30a
Working memory Digit Span (WAIS-IV)66 19a
Memory RAVLT  Immediate recall67 40
RAVLT  Delayed recall67 7
RAVLT  Recognition67 29/30
RBMT  Immediate recall68 16
RBMT  Delayed recall68 14
ROCFT  Immediate recall65 17
ROCFT  Delayed recall65 18
Information-
processing speed
TMT-A69 58a
Symbol substitution (WAIS-IV)66 39a
Stroop  Part I70 91b
Stroop  Part II70 114b
Attention TMT-B69 111
Stroop  Part III70 167
Executive 
functioning
Animal naming71 20a
/HWWHUÁXHQF\´1µ฀+฀฀A)71 11b
Rule learning (BADS)72 4
Key search test (BADS)72 2
Zoo map test (BADS)72 2
Malingering TOMM73 50/50
Notes: a16th percentile; scores below the 16th percentile of normative data are 
considered below average (impairments). b6th percentile; scores below the 6th 
SHUFHQWLOHDUHFRQVLGHUHGWRFRUUHVSRQGWRQHXURFRJQLWLYHGHÀFLWV
Abbreviations: ROCFT, Osterrieth Complex Figure Test; WAIS-IV, Wechsler 
Adult Intelligence Scale  fourth edition; RAVLT, Rey Auditory Verbal Learning 
Test; RBMT, Rivermead Behavioural Memory Test; TMT, Trail Making Test; BADS, 
Behavioral Assessment of the Dysexecutive Syndrome; TOMM, Test of Memory 
Malingering.
Figure 2 Directions of gaze that show limited range of voluntary eye movement. Up- and down-gaze are most severely affected in the patient.
Notes: (A) Patient is looking upward. (B) Patient is looking to her right. (C) Patient is looking forward. (D) Patient is looking to her left. (E) Patient is looking downward.
F G
C D E
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Figure 3 ([DPSOHRIH\HUHÁH[ZLWKÀ[DWLRQRIJD]HDQGH[DPLQHUOHGKHDGPRWLRQ
(dolls eye) of the patient.
Notes: (A) Head is moved downward by the examiner. (B) Patient is looking 
straight. (C) Head is moved upward by the examiner.
Figure 4 Hummingbird sign.
Notes: T1-weighted magnetic resonance imaging scan (taken in 2012 and 2014) of the patients brain showing selective atrophy of the midbrain with preservation of pons 
(divided by the white line), forming the silhouette of the head of the hummingbird. This feature is called the hummingbird sign.
somatic explanation for her symptoms and that she suffered 
from CD. Nevertheless, in 2015, after unsuccessful treatment 
in a rehabilitation clinic and treatment for CD at our center 
with some improvement in mental well-being, on a third 
neurological examination and MRI scan taken 6 years after 
onset of symptoms, a diagnosis of PSPS was confirmed.
Progressive supranuclear palsy
Progressive supranuclear palsy (PSP) is a neurodegenerative 
disease first described in 1963 by Richardson et al.18 The 
reported prevalence and incidence of PSP vary from 1.3 to 
4.9 and 0.3 to 1.1 per 100,000 persons, respectively. The 
disease affects both men and women. In 7% of PSP cases, 
there is a positive family history. To date, other causes and 
risk factors are unknown.19
In the classic phenotype of PSP, one of the initial features 
is impaired balance, resulting in falls, mostly backward. 
Other early features are bradykinesia, personality changes, 
which are often subtle, and bulbar symptoms, such as dys-
phagia and dysarthria. Another important symptom is vertical 
gaze limitation, and hence the name of the disease. Espe-
cially, the down-gaze limitation is specific to the diagnosis 
of PSP. This limitation could be present in the early stage of 
disease, but could also develop at a later stage. However, the 
limitation is absent in 50% of cases. Later symptoms of PSP 
are a stiff, broad-based gait; a standing posture due to axial 
rigidity; and a characteristic astonished facial expression.19 
This astonished face could resemble la belle indifférence, a 
“relative lack of concern about the nature or implication of 
the symptoms”,4,20 which has been thought to be related to 
CD in the past.21 La belle indifférence is a rare phenomenon 
Discussion
In this case, a 62-year-old woman had suffered from motor 
symptoms since 2009, for which she had consulted two dif-
ferent neurologists in 2012, who assured her that there was no 
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and appears to be seen in organic diseases nearly as often as 
in CD.5,6 The validity of la belle indifférence in the diagno-
sis of CD has been disputed,22,23 and it has been mentioned 
in the context of several neurological disorders, including 
stroke, brain tumors,24 and epilepsy.25 In a systematic review 
of 11 studies, the median frequencies of la belle indifférence 
were 21% (range 0%–54%) in 356 patients with conversion 
symptoms and 29% (range 0%–60%) in 157 patients with 
organic disease, and it was suggested that la belle indif-
férence be abandoned as a clinical sign of CD.4 In this case, 
la belle indifférence was mentioned, as the patient lacked 
mimic and had a somewhat surprised look when she dis-
cussed her symptoms. Although a neurological explanation 
for this observation was also considered, it was dismissed 
because of the negative findings in the first two neurological 
examinations.
The above-mentioned symptoms belong to the classical 
form of PSP, PSPS. Nevertheless, it appeared that other 
syndromes might have the same histopathology of PSP 
with a different distribution in the brain.19 Besides PSPS, 
several other clinical phenotypes are considered as PSP: 
PSP-parkinsonism, corticobasal syndrome, pure akinesia 
with gait freezing, progressive nonfluent aphasia, dementia 
(frontotemporal or Alzheimer-like), cerebellar ataxia, and 
motor neuron disease.19 For example, 29% of patients with 
corticobasal syndrome appeared to have the histopathology 
of PSP. We do not explain these phenotypes further in this 
case report.
A definite PSP diagnosis can only be obtained postmor-
tem by histopathological evidence of PSP pathology. When 
the patient is alive, PSPS is diagnosed on the basis of clinical 
criteria. The most frequently used criteria are the NINDS-
SPSP criteria developed under the guidance of the NINDS-
SPSP, which provides guidelines for a possible, probable, and 
definite diagnosis of PSP.16 Eye movement abnormalities and 
falls are of crucial importance for diagnosing PSPS per these 
guidelines. An MRI could be supportive as well, because it 
could reveal midbrain atrophy. On mid-sagittal images, this 
atrophy appears as a silhouette resembling a hummingbird, 
the so-called hummingbird sign.19 This sign is less visible 
on a CT scan. However, this sign may occur late during the 
disease. In contrast, midbrain atrophy was associated with 
PSP but not with PSP pathology in the absence of clinical 
PSPS,26 and the humming bird sign is therefore not always 
useful for an early diagnosis of PSP pathology. It is likely 
that atypical PSPS patients who lack evident motor symptoms 
may be referred to the psychiatric clinic rather than to the 
neurological clinic. There is no cure for PSPS. Dopamine 
can provide a short-term and modest improvement in the 
PSP-parkinsonism phenotype. Other treatments are solely 
focused on symptom relief.19
How to improve the diagnostic process
This case shows that, despite close collaboration between 
(neuro)psychologists, neurologists, and psychiatrists, PSP 
can be initially misdiagnosed as CD. With the advent of the 
DSM-5, more emphasis has been placed on neurological 
examination, wherein the neurologist plays an important 
role. In hindsight, the patient had suffered from falls since 
2009, but no symptoms could be identified during the two 
neurological examinations in 2012. In 2013, only a slightly 
unstable gait was seen. Moreover, reevaluation of the MRIs 
of 2012 and 2014 showed midbrain atrophy (hummingbird 
sign). In 2013, the patient’s surprised look was interpreted 
as la belle indifférence, whereas this may already have been 
an indication of eye movement abnormalities; however, this 
was not specifically tested at the time of the two neurological 
examinations in our center. It was only after further deterio-
ration of her condition despite adequate treatment for CD, a 
third neurological examination, and an MRI scan showing a 
hummingbird sign that the diagnosis of PSPS was established 
in 2015, 6 years after the onset of symptoms.
It should be noted that it is important to not only exclude 
neurological diseases but also find positive neurological 
indications that support the diagnosis of CD.6 There are 
neurological tests available with a high specificity for CD.27 
When some of these tests are positive, misdiagnosis of CD 
becomes less probable. Nevertheless, not all conversion 
symptoms can be evaluated by these tests.7
There were doubts from the beginning about the clas-
sification of CD in this case, as discussed earlier, because 
of some contradictory findings during the psychiatric and 
psychological examination. In particular, the existence of 
depressive symptoms is unfamiliar in CD, because affect is 
dissociated and motor or other pseudo-neurological findings 
should dominate the clinical picture in CD.
Furthermore, there were no positive neurological signs 
in the sense of incompatibility with known neurological 
disorders in the first two neurological examinations; there 
were only signs of a fluctuating presence of symptoms, which 
can be seen not only in CD but also in several neurological 
disorders, especially at onset.
The NPA findings in this case showed seriously impaired 
verbal fluency, which is characteristic of PSPS according 
to the literature.28–36 Furthermore, the specific pattern of 
impairment within the domain of verbal fluency, namely, 
more impairment within letter fluency, was found as well.37,38 
However, the NPA results of our patient showed overlap with 
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cognitive impairments as found in depressive disorder, and 
she did suffer from a concomitant depressive disorder; hence, 
the interpretation as fitting a depressive disorder was made 
initially, and only later was the link with PSPS found. Depres-
sion is often diagnosed in cases of misdiagnosed PSPS, and 
this occurred in this patient as well.39
Studies on neurocognitive impairment in patients with 
depressive disorder suggest impaired functioning across mul-
tiple cognitive domains.40 More specifically, these domains 
include information-processing speed,40,41 concentration and 
attention,40,42 various domains of memory,40,42 and executive 
functioning.40,42 Thus, the comorbidity in this case made the 
NPA findings multi-interpretable.
Based on this case, some recommendations can be made: 
neurologists who intend to refute or establish a diagnosis of 
CD should not only look for neurological disorders but also 
look actively for neurological incompatibility of findings in the 
examination. If no incompatibility is found and neurological 
examination is without abnormalities, the neurological exami-
nation should be repeated when symptoms are progressive, to 
detect slowly progressive disorders. This may be combined 
with psychiatric treatment of concomitant mental disorders 
such as, in this case, depressive disorder, or to enable the patient 
to cope with physical symptoms as much as possible.
In the case of a finding of la belle indifférence in a psy-
chiatric examination, specific testing of eye movement 
disorders should be performed, because la belle indifférence 
might be accompanied by eye movement disorders in the 
context of PSPS.
Burn and Lees emphasize that, in PSP, slowed cascades 
may precede gaze palsy, which often occurs rather late in the 
process.39 In the examination, therefore, in case of a surprised 
look, attention should be paid not only to gaze palsy but also 
to slowed cascades.
Because ophthalmologists have also been reported to 
miss PSP in cases of ophthalmological complaints, specific 
attention to this aspect is needed.
Psychiatrists might, therefore, consider consulting an 
experienced neurologist in such a case, because regular 
neurological examination by a non-neurologist, a GP, or an 
ophthalmologist may not include such tests, or they might 
have difficulty with the interpretation of the findings.
Another diagnostic consideration in la belle indifférence 
might be the presence of behavioral aspects such as lack of 
concern, which would fit with CD but not with PSPS. This 
patient was worried about her symptoms.
An NPA might be a supportive instrument in diagnosing 
PSPS because this case study confirms specific neurocognitive 
impairment in PSPS, consistent with the current literature 
about neurocognitive functioning in PSP. Cognitive and 
behavioral changes in PSP are very common and impair the 
quality of life in PSP.43 The percentage of patients who will 
show signs of dementia during the stages of disease varies 
from 10% to 70% in different studies.29,30,44 In general, PSP 
is characterized by mainly frontal disturbances in the brain.45 
Neurocognitive impairment in memory and attentional set 
shifting are found as well, but the most profound neurocog-
nitive impairments mentioned in the literature are executive 
function deficits.28,46–50 Several studies report that verbal flu-
ency is impaired in PSP.28–33 Within the domain of fluency, 
letter fluency is more impaired than semantic fluency.37,38,51,52 
However, further studies are needed to replicate such a spe-
cific neurocognitive profile in PSP in order to justify the use 
of an NPA as supportive evidence for PSP. Previous studies 
showed specific neurocognitive impairment, mainly in verbal 
fluency and more specifically in letter fluency.37,38,51
Paying attention to the preferences of the patient for 
treatment, monitoring treatment outcomes, and taking physi-
cal symptoms seriously during mental health treatment are 
of paramount importance in the treatment of patients with 
doubtful CD/incipient neurological disorder, as can be seen 
in this case. Such an approach is a common practice in 
our center.53
Moreover, this case shows how close collaboration 
between (neuro)psychologists, psychiatrists, and neurologists 
can bear fruit in establishing a final diagnosis in case of doubt 
with regard to CD. Although studies established psychiatric 
consultation with other medical specialists and GPs to be 
effective54,55 and clinical guidelines for such an approach 
exist,56,57 studies describing and evaluating the other direc-
tion, that is, consultation of neurologists by psychiatrists in 
the context of diagnosis and treatment of surmised CD, are 
lacking. In the past 5 years, several studies have emphasized 
the importance of clear communication by the neurologist in 
the diagnostic process in CD.6,58,59 However, it has been sug-
gested that although neurologists do agree that psychological 
factors may play a role in CD, they often do not discuss this 
with the patient.60 In a recent survey in the Netherlands, 
neurologists and psychiatrists deemed collaboration between 
neurologists and psychiatrists in diagnosis and treatment 
of CD as being of prime importance.61 A small pilot study 
showed promising short-term results of bidirectional consul-
tation in the diagnostic phase.62
The proportion of misdiagnosed patients with CD is 4%. 
Moreover, misdiagnosis also occurs the other way around: 
8% of patients diagnosed with multiple sclerosis appear to 
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have CD.4 Furthermore, even among patients with established 
neurological disorders, 12% present with symptoms that are 
not fully explained by the neurological disease – a phenom-
enon called “functional overlay”. In addition, the presence of 
a psychiatric history and an unusual neurological presentation 
have been the factors associated with misdiagnosis as CD.63 
This may have been the case in our study, as the patient had a 
history of incest and suffered from a depressive disorder and 
avoidant personality characteristics. Other possible factors 
that have been identified as risk factors for misdiagnosis are 
the presence of an obvious life event and la belle indifférence; 
all these factors co-occurred in our patient.64
Limitations
Obviously, this is one case report, and further research would 
be needed to establish whether misdiagnosis with CD occurs 
more often in PSPS or if it is a general phenomenon in all 
neurological disorders with an insidious course.
Strengths
To our knowledge, this is the first case reporting a patient 
with PSPS who was diagnosed with a CD. This case descrip-
tion thoroughly describes the diagnostic path of a patient 
through several medical professions, the phenomenon of la 
belle indifférence, doll’s eye phenomenon, and gaze palsy 
in a way that the clinical field can benefit from these find-
ings. Although PSPS is a fairly rare condition, lessons can 
be learnt from this description.
Research implications
Although completely avoiding misdiagnosis in CD will be 
impossible in the near future, we can minimize the prob-
ability of misdiagnosis. It would be ideal to survey more risk 
factors for misdiagnosis in CD. For example, the relation 
between signs of la belle indifférence and eye movement 
disorders or lack of mimic might be the subject of research. 
This might enable clinicians to know the factors to be aware 
of in a patient with CD. In the field of neuropsychology, 
more studies focusing on the neurocognitive component of 
PSPS should be devoted to different neurocognitive profiles 
in PSPS patients. A thoroughly described profile might 
contribute to better supportive evidence for diagnosis in an 
earlier phase of the disease.
Conclusion
This case shows that clinicians who are aware of possible 
somatic disease in patients diagnosed with CD and who col-
laborate closely can establish a diagnosis of a neurological 
disorder, even in a later phase. This is a good example of 
the benefits of a liaison between (neuro)psychologists, neu-
rologists, and psychiatrists. In particular, when the physical 
situation of a patient deteriorates despite appropriate treat-
ment of the CD, reassessment is recommended. Furthermore, 
a patient with a surprised look warrants investigation of 
saccades, and gaze should never be overlooked.
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